Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 infection

Journal of Immunology

Volumn 189, Issue 7, 2012, Pages 3449-3461

  Vicetti Miguel, Rodolfo D ^a   Hendricks, Robert L ^b   Aguirre, Alfredo J ^a   Melan, Melissa A ^b   Harvey, Stephen A K ^b   Terry Allison, Tracy ^b   St Leger, Anthony J ^b   Thomson, Angus W ^b,c   Cherpes, Thomas L ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD70 ANTIGEN; MEDROXYPROGESTERONE ACETATE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL EXPANSION; COCULTURE; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; EX VIVO STUDY; FEMALE; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; IMMUNOLOGICAL MEMORY; IMMUNOMODULATION; LATENT VIRUS INFECTION; LYMPH NODE; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HERPESVIRUS 1, HUMAN; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; KERATITIS, HERPETIC; MEDROXYPROGESTERONE ACETATE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOUS MEMBRANE;

EID: 84866555222     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1103054     Document Type: Article

References (74)

1. Morrison, C. S., P. Bright, E. L. Wong, C. Kwok, I. Yacobson, C. A. Gaydos, H. T. Tucker, and P. D. Blumenthal. 2004. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex. Transm. Dis. 31: 561-567. (Pubitemid 39122140)
2. Morrison, C. S., B. A. Richardson, F. Mmiro, T. Chipato, D. D. Celentano, J. Luoto, R. Mugerwa, N. Padian, S. Rugpao, J. M. Brown, et al. 2007. Hormonal contraception and the risk of HIV acquisition. AIDS 21: 85-95. (Pubitemid 44912541)
3. Baeten, J. M., P. M. Nyange, B. A. Richardson, L. Lavreys, B. Chohan, H. L. Martin, Jr., K. Mandaliya, J. O. Ndinya-Achola, J. J. Bwayo, and J. K. Kreiss. 2001. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am. J. Obstet. Gynecol. 185: 380-385. (Pubitemid 32769440)
4. Lavreys, L., J. M. Baeten, H. L. Martin, Jr., J. Overbaugh, K. Mandaliya, J. Ndinya-Achola, and J. K. Kreiss. 2004. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 18: 695-697. (Pubitemid 38393472)
5. Baeten, J. M., S. Benki, V. Chohan, L. Lavreys, R. S. McClelland, K. Mandaliya, J. O. Ndinya-Achola, W. Jaoko, and J. Overbaugh. 2007. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 21: 1771-1777. (Pubitemid 47237565)
6. Morrison, C. S., P. L. Chen, C. Kwok, B. A. Richardson, T. Chipato, R. Mugerwa, J. Byamugisha, N. Padian, D. D. Celentano, and R. A. Salata. 2010. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 24: 1778-1781.
7. Wang, C. C., R. S. McClelland, J. Overbaugh, M. Reilly, D. D. Panteleeff, K. Mandaliya, B. Chohan, L. Lavreys, J. Ndinya-Achola, and J. K. Kreiss. 2004. The effect of hormonal contraception on genital tract shedding of HIV-1. AIDS 18: 205-209. (Pubitemid 38253442)
8. Cherpes, T. L., M. A. Melan, J. A. Kant, L. A. Cosentino, L. A. Meyn, and S. L. Hillier. 2005. Genital tract shedding of herpes simplex virus type 2 in women: effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin. Infect. Dis. 40: 1422-1428. (Pubitemid 40628629)
9. Heffron, R., D. Donnell, H. Rees, C. Celum, N. Mugo, E. Were, G. de Bruyn, E. Nakku-Joloba, K. Ngure, J. Kiarie, et al. 2012. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect. Dis. 12: 19-26.
10. Warner, P. 2005. Concerns regarding design, analysis, and interpretation of the Morrison study on hormonal contraceptive use and acquisition of cervical infections. Sex. Transm. Dis. 32: 644-, author reply 645.
11. Gillgrass, A. E., A. A. Ashkar, K. L. Rosenthal, and C. Kaushic. 2003. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2. J. Virol. 77: 9845-9851. (Pubitemid 37122065)
12. Abel, K., T. Rourke, D. Lu, K. Bost, M. B. McChesney, and C. J. Miller. 2004. Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of Depo-Provera before intravaginal challenge with simian immunodeficiency virus mac239. J. Infect. Dis. 190: 1697-1705. (Pubitemid 39411022)
13. Genescà, M., M. B. McChesney, and C. J. Miller. 2010. Depo-Provera treatment does not abrogate protection from intravenous SIV challenge in female macaques immunized with an attenuated AIDS virus. PLoS ONE 5: e9814.
14. Knop, E., and N. Knop. 2007. Anatomy and immunology of the ocular surface. Chem. Immunol. Allergy 92: 36-49. (Pubitemid 47096895)
15. + T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation. J. Immunol. 181: 969-975.
16. Darrah, P. A., D. T. Patel, P. M. De Luca, R. W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850. (Pubitemid 47038186)
17. Decman, V., P. R. Kinchington, S. A. Harvey, and R. L. Hendricks. 2005. γ Interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression. J. Virol. 79: 10339-10347. (Pubitemid 41098574)
18. Vicetti Miguel, R. D., B. S. Sheridan, S. A. Harvey, R. S. Schreiner, R. L. Hendricks, and T. L. Cherpes. 2010. 17-β Estradiol promotion of herpes simplex virus type 1 reactivation is estrogen receptor dependent. J. Virol. 84: 565-572.
19. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
20. Sheridan, B. S., T. L. Cherpes, J. Urban, P. Kalinski, and R. L. Hendricks. 2009. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. J. Virol. 83: 2237-2245.
21. Liu, T., Q. Tang, and R. L. Hendricks. 1996. Inflammatory infiltration of the trigeminal ganglion after herpes simplex virus type 1 corneal infection. J. Virol. 70: 264-271. (Pubitemid 126508794)
22. Hanke, T., F. L. Graham, K. L. Rosenthal, and D. C. Johnson. 1991. Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides. J. Virol. 65: 1177-1186.
23. Wallace, M. E., R. Keating, W. R. Heath, and F. R. Carbone. 1999. The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J. Virol. 73: 7619-7626. (Pubitemid 29383246)
24. Kobayashi, K., N. Mimura, H. Fujii, H. Minami, Y. Sasaki, N. Shimada, and K. Chiba. 2000. Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate. Clin. Cancer Res. 6: 3297-3303. (Pubitemid 30637760)
25. Cheng, J., X. Ma, and F. J. Gonzalez. 2011. Pregnane X receptor- and CYP3A4-humanized mouse models and their applications. Br. J. Pharmacol. 163: 461-468.
26. Kirton, K. T., and J. C. Cornette. 1974. Return of ovulatory cyclicity following an intramuscular injection of medroxyprogesterone acetate (Provera). Contraception 10: 39-45.
27. Shrimanker, K., B. N. Saxena, and K. A. Fotherby. 1978. A radioimmunoassay for serum medroxyprogesterone acetate. J. Steroid Biochem. 9: 359-363. (Pubitemid 8349058)
28. Lee, A. W., D. Mitra, and J. Laurence. 1997. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV. AIDS Res. Hum. Retroviruses 13: 1235-1242. (Pubitemid 27408082)
29. Muñoz, L. D., M. J. Serramía, M. Fresno, and M. A. Muñoz-Fernández. 2007. Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion. J. Infect. Dis. 195: 1294-1302. (Pubitemid 46649614)
30. + T cell response. Immunity 25: 19-29.
31. Kim, P. S., and R. Ahmed. 2010. Features of responding T cells in cancer and chronic infection. Curr. Opin. Immunol. 22: 223-230.
32. Mueller, S. N., C. M. Jones, C. M. Smith, W. R. Heath, and F. R. Carbone. 2002. Rapid cytotoxic T lymphocyte activation occurs in the draining lymph nodes after cutaneous herpes simplex virus infection as a result of early antigen presentation and not the presence of virus. J. Exp. Med. 195: 651-656. (Pubitemid 34461510)
33. Heath, W. R., and F. R. Carbone. 2009. Dendritic cell subsets in primary and secondary T cell responses at body surfaces. Nat. Immunol. 10: 1237-1244.
34. Bedoui, S., and T. Gebhardt. 2011. Interaction between dendritic cells and T cells during peripheral virus infections: a role for antigen presentation beyond lymphoid organs? Curr. Opin. Immunol. 23: 124-130.
35. +dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J. Immunol. 170: 4437-4440.
36. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162. (Pubitemid 36152310)
37. + T cell responses to influenza. Nat. Immunol. 11: 216-224.
38. Lefrançois, L., S. Olson, and D. Masopust. 1999. A critical role for CD40-CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J. Exp. Med. 190: 1275-1284.
39. Hänninen, A., N. R. Martinez, G. M. Davey, W. R. Heath, and L. C. Harrison. 2002. Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity. J. Clin. Invest. 109: 261-267. (Pubitemid 34083746)
40. Iezzi, G., K. Karjalainen, and A. Lanzavecchia. 1998. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8: 89-95. (Pubitemid 28097826)
41. Ma, D. Y., and E. A. Clark. 2009. The role of CD40 and CD154/CD40L in dendritic cells. Semin. Immunol. 21: 265-272.
42. Medzhitov, R. 2001. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1: 135-145. (Pubitemid 33741967)
43. van Kooten, C., and J. Banchereau. 2000. CD40-CD40 ligand. J. Leukoc. Biol. 67: 2-17. (Pubitemid 30046812)
44. Cella, M., D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, and G. Alber. 1996. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184: 747-752. (Pubitemid 26324129)
45. Taraban, V. Y., T. F. Rowley, and A. Al-Shamkhani. 2004. Cutting edge: a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J. Immunol. 173: 6542-6546. (Pubitemid 39541037)
46. Murata, K., N. Ishii, H. Takano, S. Miura, L. C. Ndhlovu, M. Nose, T. Noda, and K. Sugamura. 2000. Impairment of antigen-presenting cell function in mice lacking expression of OX40 ligand. J. Exp. Med. 191: 365-374. (Pubitemid 30060925)
47. Quezada, S. A., L. Z. Jarvinen, E. F. Lind, and R. J. Noelle. 2004. CD40/CD154 interactions at the interface of tolerance and immunity. Annu. Rev. Immunol. 22: 307-328. (Pubitemid 38680425)
48. Tang, Y. C., M. Thoman, P. J. Linton, and A. Deisseroth. 2009. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged. Cancer Immunol. Immunother. 58: 1949-1957.
49. Caux, C., C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, and J. Banchereau. 1994. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med. 180: 1263-1272. (Pubitemid 24289600)
50. Lazarevic, V., A. J. Myers, C. A. Scanga, and J. L. Flynn. 2003. CD40, but not CD40L, is required for the optimal priming of T cells and control of aerosol M. tuberculosis infection. Immunity 19: 823-835. (Pubitemid 37542303)
51. Borrow, P., D. F. Tough, D. Eto, A. Tishon, I. S. Grewal, J. Sprent, R. A. Flavell, and M. B. Oldstone. 1998. CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J. Virol. 72: 7440-7449. (Pubitemid 28377875)
52. Huck, B., T. Steck, M. Habersack, J. Dietl, and U. Kämmerer. 2005. Pregnancy associated hormones modulate the cytokine production but not the phenotype of PBMC-derived human dendritic cells. Eur. J. Obstet. Gynecol. Reprod. Biol. 122: 85-94. (Pubitemid 41265686)
53. Segerer, S. E., N. Müller, J. van den Brandt, M. Kapp, J. Dietl, H. M. Reichardt, L. Rieger, and U. Kämmerer. 2009. Impact of female sex hormones on the maturation and function of human dendritic cells. Am. J. Reprod. Immunol. 62: 165-173.
54. Ferlazzo, G., and C. Münz. 2009. Dendritic cell interactions with NK cells from different tissues. J. Clin. Immunol. 29: 265-273.
55. Frank, G. M., K. A. Buela, D. M. Maker, S. A. Harvey, and R. L. Hendricks. 2012. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J. Immunol. 188: 1350-1359.
56. Chamian, F., M. A. Lowes, S. L. Lin, E. Lee, T. Kikuchi, P. Gilleaudeau, M. Sullivan-Whalen, I. Cardinale, A. Khatcherian, I. Novitskaya, et al. 2005. Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc. Natl. Acad. Sci. USA 102: 2075-2080. (Pubitemid 40262014)
57. Ghani, S., M. Feuerer, C. Doebis, U. Lauer, C. Loddenkemper, J. Huehn, A. Hamann, and U. Syrbe. 2009. T cells as pioneers: antigen-specific T cells condition inflamed sites for high-rate antigen-non-specific effector cell recruitment. Immunology 128(Suppl. 1): e870-e880.
58. Seijkens, T., D. Engel, M. Tjwa, and E. Lutgens. 2010. The role of CD154 in haematopoietic development. Thromb. Haemost. 104: 693-701.
59. Yang, L., X. Li, J. Zhao, and Y. Hou. 2006. Progesterone is involved in the maturation of murine spleen CD11c-positive dendritic cells. Steroids 71: 922-929. (Pubitemid 44286963)
60. Wieser, F., J. Hosmann, W. Tschugguel, K. Czerwenka, R. Sedivy, and J. C. Huber. 2001. Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil. Steril. 75: 1234-1235. (Pubitemid 32522629)
61. Bennett, S. R., F. R. Carbone, F. Karamalis, R. A. Flavell, J. F. Miller, and W. R. Heath. 1998. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393: 478-480.
62. + effector T cell responses. J. Immunol. 164: 3689-3697.
63. Yang, Y., and J. M. Wilson. 1996. CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40. Science 273: 1862-1864. (Pubitemid 26322496)
64. Chen, L., W. Cheng, P. Shivshankar, L. Lei, X. Zhang, Y. Wu, I. T. Yeh, and G. Zhong. 2009. Distinct roles of CD28- and CD40 ligand-mediated costimulation in the development of protective immunity and pathology during Chlamydia muridarum urogenital infection in mice. Infect. Immun. 77: 3080-3089.
65. Reichmann, G., W. Walker, E. N. Villegas, L. Craig, G. Cai, J. Alexander, and C. A. Hunter. 2000. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect. Immun. 68: 1312-1318. (Pubitemid 30108527)
66. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4: 283-289. (Pubitemid 26131011)
67. Masopust, D., J. Jiang, H. Shen, and L. Lefrançois. 2001. Direct analysis of the dynamics of the intestinal mucosa CD8 T cell response to systemic virus infection. J. Immunol. 166: 2348-2356. (Pubitemid 32173468)
68. Winkelstein, J. A., M. C. Marino, H. Ochs, R. Fuleihan, P. R. Scholl, R. Geha, E. R. Stiehm, and M. E. Conley. 2003. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine 82: 373-384. (Pubitemid 37445041)
69. Hughes, G. C., S. Thomas, C. Li, M. K. Kaja, and E. A. Clark. 2008. Cutting edge: progesterone regulates IFN-α production by plasmacytoid dendritic cells. J. Immunol. 180: 2029-2033.
70. Jones, L. A., S. Kreem, M. Shweash, A. Paul, J. Alexander, and C. W. Roberts. 2010. Differential modulation of TLR3- and TLR4-mediated dendritic cell maturation and function by progesterone. J. Immunol. 185: 4525-4534.
71. Ortiz, A., M. Hirol, F. Z. Stanczyk, U. Goebelsmann, and D. R. Mishell. 1977. Serum medroxyprogesterone acetate (MPA) concentrations and ovarian function following intramuscular injection of depo-MPA. J. Clin. Endocrinol. Metab. 44: 32-38. (Pubitemid 8030779)
72. Mishell, D. R., Jr. 1996. Pharmacokinetics of depot medroxyprogesterone acetate contraception. J. Reprod. Med. 41(Suppl. 5): 381-390.
73. Smit, J., J. Botha, L. McFadyen, and M. Beksinska. 2004. Serum medroxyprogesterone acetate levels in new and repeat users of depot medroxyprogesterone acetate at the end of the dosing interval. Contraception 69: 3-7. (Pubitemid 38076958)
74. Africander, D., N. Verhoog, and J. P. Hapgood. 2011. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception. Steroids 76: 636-652.